Inhaled steroids have been used for many years. The first report of their beneficial use in asthmatic children was published almost 30 yrs ago [1]. With increasing knowledge of the side-effects of systemically administered steroids, there has been a steady increase in the use of inhaled steroids, and they are presently considered to be the most important treatment for asthma. Inhaled steroids are the cornerstone of all guidelines on asthma treatment [2][3][4]. They reduce symptoms in children with asthma [5], improve quality of life in asthmatic children and their families [6], decrease patients9 and their parents9 absence from school/work [7], reduce airway inflammation [8], and improve lung function [9], bronchial responsiveness [10] and exercise-induced asthma [11,12]. The sale and use of inhaled steroids has markedly increased in Nordic countries since the late 1980s, which has probably had an impact upon the admission rate of childhood asthma in these countries. In older children, the admission [13] and particularly readmission [14] rates for acute asthma have decreased in these countries. The use of inhaled steroids has thus had a major impact upon daily life and the "mastering" of asthma in asthmatic children.Despite the beneficial effects of inhaled steroids in childhood asthma, general agreement as to how early to start treatment has not been reached. This is mostly due to the general fear of the side-effects of inhaled steroids, but also because of an awareness of the possible effects upon lung growth in young children, as has been reported by the use of systemic steroids in animal experiments [15].The local side-effects of inhaled steroids on skin, the mucous membranes of the respiratory tract, and the oropharyngeal area are also well known, but have received much less attention than the systemic sideeffects. The local side-effects consist of perioral dermatitis, oral candidiasis, hoarseness, dysphonia, cough during inhalation and a feeling of thirst [16].However, systemic side-effects, including suppression of the hypothalamic-hypophyseal-adrenal axis [17][18][19] Posterior subcapsular cataracts have been described as developing after systemic steroids have been used and, in three patients, on inhaled beclomethasone dipropionate with occasional short courses of systemic steroids over several years [25]. However, systematic studies have not indicated an increased risk of cataracts with the use of inhaled steroids [26,27].Although practical experience throughout the past 30 yrs has proved that inhaled steroids are safe drugs for most patients, it has also been shown that in higher doses, a systemic effect is detectable by demonstrating an early morning dip in serum cortisol when measuring 24-h integrated and fractionated (overnight, 08.00 h, daytime) serum cortisol levels and urinary cortisol/creatinine excretion [28,29]. Stimulation tests have also been used to detect the effect of inhaled steroids on the hypothalamicpituitary-adrenal axis [29]. After a meta-analysis including 27 studies performed dur...